Grufity logoGrufity logo

Encompass Health Corp Stock Research

EHC

52.97USD+0.91(+1.75%)Market Closed

Market Summary

USD52.97+0.91
Market Closed
1.75%

EHC Alerts

EHC Stock Price

EHC RSI Chart

EHC Valuation

Market Cap

5.3B

Price/Earnings (Trailing)

19.39

Price/Sales (Trailing)

1.21

EV/EBITDA

9.17

Price/Free Cashflow

37.27

EHC Price/Sales (Trailing)

EHC Profitability

EBT Margin

10.37%

Return on Equity

20.68%

Return on Assets

4.81%

Free Cashflow Yield

2.68%

EHC Fundamentals

EHC Revenue

Revenue (TTM)

4.3B

Revenue Y/Y

9.09%

Revenue Q/Q

4.39%

EHC Earnings

Earnings (TTM)

271.0M

Earnings Y/Y

-2.4%

Earnings Q/Q

96.92%

Price Action

52 Week Range

41.9864.90
(Low)(High)

Last 7 days

-4.4%

Last 30 days

-15.5%

Last 90 days

-9.6%

Trailing 12 Months

-2.9%

EHC Financial Health

Current Ratio

1.25

Debt/Equity

2.09

Debt/Cashflow

0.26

EHC Investor Care

Dividend Yield

1.62%

Dividend/Share (TTM)

0.86

Shares Dilution (1Y)

0.20%

Diluted EPS (TTM)

2.7

Peers (Alternatives to Encompass Health)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
70.6B
60.2B
-4.86% -6.89%
12.5
1.17
2.52% -18.88%
19.6B
14.9B
-11.65% -18.57%
15.35
1.32
-7.72% -46.20%
15.5B
9.9B
-9.17% -4.78%
16.43
1.57
-8.39% -52.58%
MID-CAP
8.8B
13.4B
-20.72% -21.03%
13
0.66
5.99% -31.87%
7.1B
11.6B
-9.20% -31.27%
12.59
0.61
-0.08% -42.73%
6.1B
19.2B
-9.72% -38.02%
6.13
0.32
-1.60% -32.18%
5.3B
4.3B
-15.50% -2.92%
19.39
1.21
8.31% -34.26%
4.1B
2.5B
-9.79% -38.94%
-74.24
1.6
14.12% 22.99%
3.3B
6.3B
-15.00% 4.69%
20.58
0.52
2.08% -60.47%
SMALL-CAP
1.6B
951.1M
-7.28% 30.41%
34.53
1.67
10.02% 1.99%
1.3B
1.4B
12.22% 10.36%
120.12
0.89
8.74% -56.93%
724.7M
12.2B
-1.54% -55.54%
15.75
0.06
-1.27% -80.00%
524.3M
2.8B
-3.12% -59.80%
-2.2
0.19
2.43% -140.13%
7.5M
45.8M
-2.78% -21.05%
-2.54
0.16
11.66% -153.83%

Financials for Encompass Health

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue2.2%4,3494,2544,1754,1144,015
  S&GA Expenses-19.8%154192193187170
EBITDA-2.3%8708911,1011,053-
EBITDA Margin-4.4%0.20*0.21*0.19*0.20*-
Earnings Before Taxes-1.7%451458479566505
EBT Margin-3.8%0.10*0.11*0.11*0.12*-
Interest Expenses-1.5%176178180161164
Net Income-0.8%271273328392412
Net Income Margin-3.0%0.06*0.06*0.06*0.08*-
Free Cahsflow56.3%14190.00219231-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets2.9%5,6375,4767,0826,9446,865
  Current Assets-2.3%7177341,032950921
    Cash Equivalents-63.5%22.0060.0018794.0049.00
  Goodwill1.3%1,2631,2472,4572,4571,237
Liabilities1.2%3,7753,7284,5384,4524,466
  Current Liabilities-4.8%576605835755749
  Long Term Debt0.8%2,7422,7193,2343,2213,241
Shareholder's Equity7.7%1,3101,2172,5012,4481,911
  Retained Earnings-18.4%116142---
  Additional Paid-In Capital-24.4%1,7302,290---
Shares Outstanding0%99.0099.00125--
Minority Interest4.7%516493498475446
Cashflow (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations7.4%706657765776716
  Share Based Compensation-4.6%29.0031.0031.0034.0029.00
Cashflow From Investing2.2%-627-641-591-693-666
Cashflow From Financing-67.7%-145-86.90-56.40-223-240
  Dividend Payments-11.4%99.00112112112112
  Buy BacksNaN%0.000.00---

Risks for EHC

What is the probability of a big loss on EHC?

67.7%


Probability that Encompass Health stock will be more than 20% underwater in next one year

31.9%


Probability that Encompass Health stock will be more than 30% underwater in next one year.

0%


Probability that Encompass Health stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does EHC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Encompass Health was unfortunately bought at previous high price.

Drawdowns

Returns for EHC

Cumulative Returns on EHC

12.0%


10-Year Cumulative Returns

11.1%


7-Year Cumulative Returns

4.1%


5-Year Cumulative Returns

2.2%


3-Year Cumulative Returns

What are the long-term rolling returns for EHC?

FIve years rolling returns for Encompass Health.

Annualized Returns

Which funds bought or sold EHC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
3.03
37,494,400
140,961,000
0.15%
2023-03-06
Rockefeller Capital Management L.P.
added
3.94
4,000
15,000
-%
2023-02-28
Voya Investment Management LLC
added
4.51
224,997
812,997
-%
2023-02-24
SRS Capital Advisors, Inc.
reduced
-13.76
634
5,634
-%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
161
1,708,000
2,403,000
0.03%
2023-02-21
NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC
reduced
-35.92
-99,714
552,286
0.01%
2023-02-21
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
unchanged
-
316
1,316
-%
2023-02-21
MACQUARIE GROUP LTD
reduced
-15.6
4,916,000
48,007,000
0.06%
2023-02-21
Ruedi Wealth Management, Inc.
new
-
12,082
12,082
0.01%
2023-02-17
TRUIST FINANCIAL CORP
reduced
-1.14
3,796,510
16,153,500
0.03%

1–10 of 44

Latest Funds Activity

Are funds buying EHC calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own EHC
No. of Funds

Encompass Health News

Nasdaq

We Did The Math XMLV Can Go To $60.

Nasdaq,
32 hours ago

DirectorsTalk Interviews

Knoxville News Sentinel

Schedule 13G FIlings of Encompass Health

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
9.77%
9,749,441
SC 13G/A
Feb 06, 2023
wellington management group llp
9.58%
9,558,849
SC 13G/A
Jan 30, 2023
blackrock inc.
11.3%
11,232,620
SC 13G/A
Jan 30, 2023
blackrock inc.
11.3%
11,232,620
SC 13G/A
Feb 10, 2022
vanguard group inc
9.46%
9,414,569
SC 13G/A
Feb 04, 2022
wellington management group llp
10.58%
10,524,661
SC 13G/A
Jan 27, 2022
blackrock inc.
10.7%
10,643,463
SC 13G/A
Jan 25, 2022
blackrock inc.
10.7%
10,643,463
SC 13G/A
Feb 11, 2021
william blair investment management, llc
4.70%
4,666,500
SC 13G/A
Feb 10, 2021
vanguard group inc
9.05%
8,998,232
SC 13G/A

EHC Fair Value

Encompass Health fair value in different scenarios

The table shows the Fair Value estimates for Encompass Health for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

-

-

-

-

-

-

-

-

-

-
Current Inflation

23.57

-55.50%

35.05

-33.83%

50.03

-5.55%

61.65

16.39%

72.40

36.68%
Very High Inflation

-

-

-

-

-

-

-

-

-

-

Historical Encompass Health Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Encompass Health

View All Filings
Date Filed Form Type Document
Mar 14, 2023
8-K
Current Report
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading

Latest Insider Trading transactions for EHC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-02-27
Darby John Patrick
sold (taxes)
-30,652
60.22
-509
evp, gen counsel & secretary
2023-02-27
Tarr Mark J
sold (taxes)
-174,337
60.22
-2,895
president & ceo
2023-02-27
Price Andrew L
sold (taxes)
-24,690
60.22
-410
chief accounting officer
2023-02-27
Charbonneau Elissa Joy
sold (taxes)
-30,471
60.22
-506
chief medical officer
2023-02-27
COLTHARP DOUGLAS E
sold (taxes)
-64,917
60.22
-1,078
evp & chief financial officer
2023-02-27
Fay Edmund
sold (taxes)
-23,064
60.22
-383
sr. vice pres. and treasurer
2023-02-24
COLTHARP DOUGLAS E
sold (taxes)
-50,584
60.22
-840
evp & chief financial officer
2023-02-24
Price Andrew L
sold (taxes)
-19,270
60.22
-320
chief accounting officer
2023-02-24
Fay Edmund
sold (taxes)
-18,005
60.22
-299
sr. vice pres. and treasurer
2023-02-24
Darby John Patrick
sold (taxes)
-23,907
60.22
-397
evp, gen counsel & secretary

1–10 of 50

Mark J. Tarr
43400
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of April 11, 2022, it operated 147 hospitals, 251 home health locations, and 96 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

EHC Income Statement

2022-12-31
Consolidated Statements of Comprehensive Income - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income and Income Statement [Abstract]   
Net operating revenues$ 4,348.6$ 4,014.9$ 3,566.3
Operating expenses:   
Salaries and benefits2,393.32,127.31,903.8
Other operating expenses670.4595.9545.1
Occupancy costs54.759.061.4
Supplies202.1184.2171.0
General and administrative expenses154.3169.5151.6
Depreciation and amortization243.6219.6203.0
Government, class action, and related settlements0.00.02.8
Total operating expenses3,718.43,355.53,038.7
Loss on early extinguishment of debt1.41.02.3
Interest expense and amortization of debt discounts and fees175.7164.3183.7
Other expense (income)5.2(7.5)(8.4)
Equity in net income of nonconsolidated affiliates(2.9)(3.4)(2.9)
Income from continuing operations before income tax expense450.8505.0352.9
Provision for income tax expense100.1101.974.7
Income from continuing operations350.7403.1278.2
Income from discontinued operations, net of tax15.2114.190.6
Net and comprehensive income365.9517.2368.8
Net and comprehensive income365.9517.2368.8
Less: Net income attributable to noncontrolling interests included in continuing operations(93.6)(103.2)(83.3)
Less: Net income attributable to noncontrolling interests included in discontinued operations(1.3)(1.8)(1.3)
Less: Net and comprehensive income attributable to noncontrolling interests(94.9)(105.0)(84.6)
Less: Net and comprehensive income attributable to noncontrolling interests(94.9)(105.0)(84.6)
Net and comprehensive income attributable to Encompass Health271.0412.2284.2
Net and comprehensive income attributable to Encompass Health$ 271.0$ 412.2$ 284.2
Weighted average common shares outstanding:   
Basic (in shares)99.299.098.6
Diluted (in shares)100.4100.299.8
Basic earnings per share attributable to Encompass Health common shareholders:   
Continuing operations (in dollars per share)$ 2.58$ 3.02$ 1.97
Discontinued operations (in dollars per share)0.141.130.90
Net income (in dollars per share)2.724.152.87
Diluted earnings per share attributable to Encompass Health common shareholders:   
Continuing operations (in dollars per share)2.562.991.96
Discontinued operations (in dollars per share)0.141.120.89
Net income (in dollars per share)$ 2.70$ 4.11$ 2.85
Amounts attributable to Encompass Health:   
Income from continuing operations$ 257.1$ 299.9$ 194.9
Income from discontinued operations, net of tax13.9112.389.3
Net and comprehensive income attributable to Encompass Health$ 271.0$ 412.2$ 284.2

EHC Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 21.8$ 49.4
Restricted cash31.662.5
Accounts receivable536.8515.8
Prepaid expenses and other current assets127.0114.9
Current assets of discontinued operations0.0178.8
Total current assets717.2921.4
Property and equipment, net2,939.22,581.2
Operating lease right-of-use assets212.5193.7
Goodwill1,263.21,237.0
Intangible assets, net282.3158.4
Other long-term assets222.0230.0
Noncurrent assets of discontinued operations0.11,543.2
Total assets[1]5,636.56,864.9
Current liabilities:  
Current portion of long-term debt25.237.8
Current operating lease liabilities25.623.5
Accounts payable132.9134.0
Accrued payroll168.3199.4
Accrued interest payable42.844.4
Other current liabilities181.0177.3
Current liabilities of discontinued operations0.1132.4
Total current liabilities575.9748.8
Long-term debt, net of current portion2,741.83,240.5
Long-term operating lease liabilities199.7179.6
Self-insured risks128.5123.8
Deferred income tax liabilities83.023.3
Other long-term liabilities45.348.9
Noncurrent liabilities of discontinued operations0.4100.8
Total liabilities3,774.64,465.7
Commitments and contingencies
Redeemable noncontrolling interests35.642.2
Encompass Health shareholders’ equity:  
Common stock, $.01 par value; 200,000,000 shares authorized; issued: 114,775,056 in 2022; 114,211,057 in 20211.11.1
Capital in excess of par value1,730.22,289.6
Accumulated income115.7141.8
Treasury stock, at cost (14,992,125 shares in 2022 and 14,719,662 shares in 2021)(536.7)(521.2)
Total Encompass Health shareholders’ equity1,310.31,911.3
Noncontrolling interests516.0445.7
Total shareholders’ equity1,826.32,357.0
Liabilities and Equity, Total[1]$ 5,636.5$ 6,864.9
[1]Our consolidated assets as of December 31, 2022 and December 31, 2021 include total assets of variable interest entities of $207.8 million and $226.2 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2022 and December 31, 2021 include total liabilities of the variable interest entities of $47.9 million and $38.2 million, respectively. See Note 4, Variable Interest Entities.